NCT01441557View on ClinicalTrials.gov

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Botulism
Interventions
DRUG

3,4-diaminopyridine

test dose 10 mg then 20 mg, then depending on tolerance and efficacy full-dose administration(from 10mg /8h to 20 mg /8h)

Trial Locations (1)

80000

CHU, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT01441557 - Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism | Biotech Hunter | Biotech Hunter